These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5109312)

  • 1. [Action of 5 per cent guanethidine sulfate (ismeline) eye drops on lid retraction during Basedow's disease].
    Storch J
    Ann Ocul (Paris); 1971 Jun; 204(6):627-44. PubMed ID: 5109312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of guanethidine eyedrops on the ocular manifestations of Basedow's disease].
    Berkman N; Joseph E
    Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(8):617-28. PubMed ID: 4256931
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ocular manifestations of Basedow's disease and local administration of guanethidine].
    Berkman N; Joseph E
    Presse Med (1893); 1971 Jan; 79(3):83-6. PubMed ID: 5107433
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.
    Cartlidge NE; Crombie AL; Anderson J; Hall R
    Br Med J; 1969 Dec; 4(5684):645-7. PubMed ID: 4902494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retraction of the eyelids of endocrine origin treated with guanethidine (Ismelin) eyedrops].
    Kjer P
    Ugeskr Laeger; 1968 Jan; 130(1):10-3. PubMed ID: 5694737
    [No Abstract]   [Full Text] [Related]  

  • 6. Mueller's muscle: to relax or to incise.
    Haddad HM
    Metab Pediatr Syst Ophthalmol (1985); 1995; 18(1-4):15-8. PubMed ID: 9064490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of guanethidine in preventing the retraction of the upper lid in Graves' disease].
    Chwirot R; Gliński J
    Klin Oczna; 1972; 42(3):883-4. PubMed ID: 5067657
    [No Abstract]   [Full Text] [Related]  

  • 8. [Elongation of the levator palpebrae superioris in palpebral retraction in Basedow's disease].
    Dufour V; Ernst S; Montard M
    J Fr Ophtalmol; 1993; 16(6-7):415-6. PubMed ID: 8360427
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of guanethidine eye drops in dysthyroid lid retraction.
    Martin B; Jay B
    Proc R Soc Med; 1969 Jan; 62(1):18-9. PubMed ID: 5763459
    [No Abstract]   [Full Text] [Related]  

  • 10. Graded full-thickness anterior blepharotomy for upper eyelid retraction.
    Elner VM; Hassan AS; Frueh BR
    Trans Am Ophthalmol Soc; 2003; 101():67-73; discussion 73-5. PubMed ID: 14971565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.
    Cant JS; Lewis DR
    Br J Ophthalmol; 1969 Apr; 53(4):239-45. PubMed ID: 5818670
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of dysthyroid ophthalmopathy with local guanethidine.
    Cant JS; Lewis DR; Harrison MT
    Br J Ophthalmol; 1969 Apr; 53(4):233-8. PubMed ID: 5818669
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical approach to ophthalmopathy of Graves' disease.
    Ivy HK
    Mayo Clin Proc; 1972 Dec; 47(12):980-5. PubMed ID: 4404646
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of darkness on upper eyelid position.
    Neves LC; Cruz AA
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):112-6. PubMed ID: 15778664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Edema of the eyelid disclosing Basedow's disease].
    Derancourt C; Humbert P; Buchet S; Blanc D; Agache P
    Ann Dermatol Venereol; 1992; 119(8):555-6. PubMed ID: 1485758
    [No Abstract]   [Full Text] [Related]  

  • 16. Guanethidine drops in thyroid eye disease.
    Millar GT
    Trans Ophthalmol Soc U K (1962); 1969; 88():677-9. PubMed ID: 5272285
    [No Abstract]   [Full Text] [Related]  

  • 17. A single transcutaneous injection with Botox for dysthyroid lid retraction.
    Shih MJ; Liao SL; Lu HY
    Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment for upper lid retraction of dysthyroidism.
    Chuenkongkaew W
    J Med Assoc Thai; 2003 Nov; 86(11):1051-4. PubMed ID: 14696787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysthyroid eye disease. A trial of guanethidine eye drops.
    Bowden AN; Rose FC
    Br J Ophthalmol; 1969 Apr; 53(4):246-51. PubMed ID: 4889097
    [No Abstract]   [Full Text] [Related]  

  • 20. Unilateral eyelid retraction secondary to contralateral ptosis in dysthyroid ophthalmopathy.
    Lohman L; Burns JA; Penland WR; Cahill KV
    J Clin Neuroophthalmol; 1984 Sep; 4(3):163-6. PubMed ID: 6238052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.